First Allied Advisory Services’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-46,100
| Closed | -$413K | – | 1233 |
|
|
2020
Q2 | $413K | Buy |
46,100
+185
| +0.4% | +$1.66K | 0.02% | 712 |
|
|
2020
Q1 | $292K | Hold |
45,915
| – | – | 0.01% | 768 |
|
|
2019
Q4 | $385K | Buy |
45,915
+10,000
| +28% | +$83.9K | 0.01% | 810 |
|
|
2019
Q3 | $325K | Buy |
35,915
+5,800
| +19% | +$52.5K | 0.01% | 854 |
|
|
2019
Q2 | $324K | Buy |
30,115
+14,000
| +87% | +$151K | 0.01% | 854 |
|
|
2019
Q1 | $154K | Sell |
16,115
-84
| -0.5% | -$803 | 0.01% | 1080 |
|
|
2018
Q4 | $185K | Hold |
16,199
| – | – | 0.01% | 972 |
|
|
2018
Q3 | $273K | Buy |
+16,199
| New | +$273K | 0.01% | 952 |
|